Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1CNS 1

Conditions

Melanoma 19Thyroid Neoplasms 7Glioma 6Thyroid Carcinoma, Anaplastic 5Multiple Myeloma 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Thyroid Cancer, Papillary 3Hematologic Neoplasms 3Skin Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Lymphoma 2Lung Neoplasms 2Histiocytosis, Langerhans-Cell 2Glioblastoma 2Colonic Neoplasms 2Brain Neoplasms 2Astrocytoma 2Adenocarcinoma, Follicular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Sarcoma 1

Interventions

trametinib 1mirdametinib 1gallium Ga 68 dotatate 1dabrafenib 1Magnetic Resonance Spectroscopy 1Ga(III)-DOTATOC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroma × dabrafenib × 1 year × Clear all
NCT03975829 2026-06-02

Pediatric Long-Term Follow-up and Rollover Study

Novartis

Phase 4 Recruiting
165 enrolled
CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡